Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 31.98
+2.60 (8.85%)
Apr 17, 2026, 4:08 PM HKT
HKG:3378 Revenue
In the year 2025, Hanx Biopharmaceuticals (Wuhan) had annual revenue of 16.62M CNY with 655.62% growth.
Revenue
16.62M CNY
Revenue Growth
+655.62%
P/S Ratio
42,550.51
Revenue / Employee
302.11K CNY
Employees
55
Market Cap
4.36B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.62M | 14.42M | 655.62% |
| Dec 31, 2024 | 2.20M | -340.00K | -13.39% |
| Dec 31, 2023 | 2.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition